LivingGLP1
Study S000894

The Effects of Semaglutide on Modulation of Taste Sensitivity, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Responses in Women With PCOS and Obesity: a Randomized, Single-blind, Placebo-controlled Clinical Trial

Registration

Registration
NCT04263415
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
SINGLE
Status
COMPLETED
Enrollment
30
Start
2019-11-02
Primary completion
2020-05-08
Lead sponsor
University Medical Centre Ljubljana
Conditions
PCOS; Semaglutide; Taste, Altered; Tongue Tissue Transcriptome; Gastric Emptying; Central Neural Response
Interventions
DRUG:Semaglutide; OTHER:Placebo
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • to investigate the effect of semaglutide on taste perception as change in taste sensitivity detected by chemical gustometry evaluated with "Taste strips" test [Changes in taste perception from baseline up to the end of 12th week.]
  • CO-PRIMARY END-POINT : to investigate alteration of transcriptomic profile of human tongue tissue as changes in expression level from baseline to follow up after 12 weeks of treatment, measured by RNA sequencing [Change in transcriptomic profile from baseline up to the end of 12th week.]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R00555746468 Once-Weekly Semaglutide and Taste Perception in Women with Obesity
M Jensterle Sever, Journal of the Endocrine Society
2024Randomized trialDOIcites ClinicalTrials.gov:NCT04263415
R0015032Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial.
Jensterle M, Trials
2021ProtocolPMID 34281590DOIcites ClinicalTrials.gov:NCT04263415; registry reference DERIVED:34281590